Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

Subjects:

The global prevalence of gynecological diseases among women aged 15-49 years in 1990 and 2021, along with the trends and changes observed between these years. by Xiaofeng He (2618752)

Subjects:

Raw data underlying the quantitative results reported in the manuscript. by Lai Jiang (2401513)

Figure 4 from Impact of Glucocorticoids on Immune Checkpoint Inhibitor Efficacy and Circulating Biomarkers in Non–Small Cell Lung Cancer Patients by Lauren Polyakov (21672045)

Each subfigure shows a different local size (LS) and context size (CS) configuration, where the reliability of the model across different initializations is measured in R-squared. by Eloy Geenjaar (21533195)

“…<p>In most cases where both the local size and context size is small, the DSVAE model is significantly more reliable than the IDSVAE method. …”

Raw data. by Adrian Bartoszek (20826922)

“…The addition of 15 mg/L CAF to TPM did not affect larval activity at any TPM concentration tested; however, higher doses of CAF significantly reduced larval activity. …”

Equivalent effect model. by Xueting Ma (390540)

Subjects:

Simulation model. by Xueting Ma (390540)

Subjects:

Decomposition analysis of the changes in the number of deaths from hypertension-attributable AA in different SDI regions from 1990 to 2021. by Guanghui Yu (423945)

Subjects:

Deaths and ASMR of AA^a due to Hypertension in 1990 and 2021, along with the EAPC from 1990 to 2021. by Guanghui Yu (423945)

Subjects:

Decomposition analysis of the changes in AA deaths attributed to hypertension across diverse SDI regions from 1990 to 2021. by Guanghui Yu (423945)

Subjects:

ANOVA for the quadratic polynomial regression model of several soil-disturbed particles. by Xueting Ma (390540)

Subjects:

Differentially expressed protein in the Model group and the WKY group. by Xiao Zhang (152326)

Subjects:

The ASDR of hypertension – related AA in different age groups of man worldwide from 2022 to 2050 predicted by the BAPC model. by Guanghui Yu (423945)

Subjects:

The ASDR of hypertension-related AA stratified by gender in different SDI from 1990 to 2021. by Guanghui Yu (423945)

Subjects: